Status:
UNKNOWN
Isotretinoin in Treatment of COVID-19
Lead Sponsor:
Tanta University
Conditions:
COVID-19
Eligibility:
All Genders
18-40 years
Phase:
PHASE3
Brief Summary
Contributors: Lamia Elgarhy, Sabah El-Gaeish 1, Eman Hamed 2 , Wagdy Fathy2 Department of Dermatology, Department of Pharmacology1 , Faculty of Medicine, Tanta University, Department of Chest, Facult...
Detailed Description
The study is a randomized interventional comparative Phase III trial. The duration of the trial for each subject is expected to be 3 months. The duration for each individual subject includes one-month...
Eligibility Criteria
Inclusion
- Clinical and laboratory diagnosis of COVID-19.
- Age range 18-40
Exclusion
- Hypercholesterolemia
- Hypertriglyceridemia
- Liver disease
- Renal disease
- Sjögren syndrome
- Pregnancy
- Lactation
- Depressive disorder
- Contraindications for hormonal contraception or intrauterine device.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04361422
Start Date
December 1 2020
End Date
December 1 2021
Last Update
September 23 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.